NSE:SEQUENT   SEQUENT SCIENTIFIC
PE is negative at -42

THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED

Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane

Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years

Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition

mutual funds have increased stake from 0.25% to 1%

DII also increasing stake significantly

stock has come out of accumulation Phase!!!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.